Global Seasonal Allergic Rhinitis Drug Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Seasonal Allergic Rhinitis Drug market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Seasonal Allergic Rhinitis Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Seasonal Allergic Rhinitis Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Seasonal Allergic Rhinitis Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Seasonal Allergic Rhinitis Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Seasonal Allergic Rhinitis Drug include Allergy Therapeutics Plc, Faes Farma, S.A., Glenmark Pharmaceuticals Ltd., Hisamitsu Pharmaceutical Co., Inc., Shionogi & Co., Ltd., VentiRx Pharmaceuticals, Inc., Pfizer Inc. and Merck & Co., Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Seasonal Allergic Rhinitis Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Seasonal Allergic Rhinitis Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Seasonal Allergic Rhinitis Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Seasonal Allergic Rhinitis Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Seasonal Allergic Rhinitis Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Seasonal Allergic Rhinitis Drug sales, projected growth trends, production technology, application and end-user industry.

Seasonal Allergic Rhinitis Drug Segment by Company

Allergy Therapeutics Plc
Faes Farma, S.A.
Glenmark Pharmaceuticals Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Shionogi & Co., Ltd.
VentiRx Pharmaceuticals, Inc.
Pfizer Inc.
Merck & Co., Inc.

Seasonal Allergic Rhinitis Drug Segment by Type

VTX-1463
PF-06444753
GSP-301
Others

Seasonal Allergic Rhinitis Drug Segment by Application

Clinic
Hospital
Others

Seasonal Allergic Rhinitis Drug Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Allergic Rhinitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Seasonal Allergic Rhinitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Allergic Rhinitis Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Seasonal Allergic Rhinitis Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Seasonal Allergic Rhinitis Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Seasonal Allergic Rhinitis Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Seasonal Allergic Rhinitis Drug Market by Type
1.2.1 Global Seasonal Allergic Rhinitis Drug Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 VTX-1463
1.2.3 PF-06444753
1.2.4 GSP-301
1.2.5 Others
1.3 Seasonal Allergic Rhinitis Drug Market by Application
1.3.1 Global Seasonal Allergic Rhinitis Drug Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Seasonal Allergic Rhinitis Drug Market Dynamics
2.1 Seasonal Allergic Rhinitis Drug Industry Trends
2.2 Seasonal Allergic Rhinitis Drug Industry Drivers
2.3 Seasonal Allergic Rhinitis Drug Industry Opportunities and Challenges
2.4 Seasonal Allergic Rhinitis Drug Industry Restraints
3 Global Market Growth Prospects
3.1 Global Seasonal Allergic Rhinitis Drug Revenue Estimates and Forecasts (2020-2031)
3.2 Global Seasonal Allergic Rhinitis Drug Revenue by Region
3.2.1 Global Seasonal Allergic Rhinitis Drug Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Seasonal Allergic Rhinitis Drug Revenue by Region (2020-2025)
3.2.3 Global Seasonal Allergic Rhinitis Drug Revenue by Region (2026-2031)
3.2.4 Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Region (2020-2031)
3.3 Global Seasonal Allergic Rhinitis Drug Sales Estimates and Forecasts 2020-2031
3.4 Global Seasonal Allergic Rhinitis Drug Sales by Region
3.4.1 Global Seasonal Allergic Rhinitis Drug Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Seasonal Allergic Rhinitis Drug Sales by Region (2020-2025)
3.4.3 Global Seasonal Allergic Rhinitis Drug Sales by Region (2026-2031)
3.4.4 Global Seasonal Allergic Rhinitis Drug Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Seasonal Allergic Rhinitis Drug Revenue by Manufacturers
4.1.1 Global Seasonal Allergic Rhinitis Drug Revenue by Manufacturers (2020-2025)
4.1.2 Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Seasonal Allergic Rhinitis Drug Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Seasonal Allergic Rhinitis Drug Sales by Manufacturers
4.2.1 Global Seasonal Allergic Rhinitis Drug Sales by Manufacturers (2020-2025)
4.2.2 Global Seasonal Allergic Rhinitis Drug Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Seasonal Allergic Rhinitis Drug Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Seasonal Allergic Rhinitis Drug Sales Price by Manufacturers (2020-2025)
4.4 Global Seasonal Allergic Rhinitis Drug Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Seasonal Allergic Rhinitis Drug Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Seasonal Allergic Rhinitis Drug Manufacturers, Product Type & Application
4.7 Global Seasonal Allergic Rhinitis Drug Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Seasonal Allergic Rhinitis Drug Market CR5 and HHI
4.8.2 2024 Seasonal Allergic Rhinitis Drug Tier 1, Tier 2, and Tier 3
5 Seasonal Allergic Rhinitis Drug Market by Type
5.1 Global Seasonal Allergic Rhinitis Drug Revenue by Type
5.1.1 Global Seasonal Allergic Rhinitis Drug Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Seasonal Allergic Rhinitis Drug Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Type (2020-2031)
5.2 Global Seasonal Allergic Rhinitis Drug Sales by Type
5.2.1 Global Seasonal Allergic Rhinitis Drug Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Seasonal Allergic Rhinitis Drug Sales by Type (2020-2031) & (W Units)
5.2.3 Global Seasonal Allergic Rhinitis Drug Sales Market Share by Type (2020-2031)
5.3 Global Seasonal Allergic Rhinitis Drug Price by Type
6 Seasonal Allergic Rhinitis Drug Market by Application
6.1 Global Seasonal Allergic Rhinitis Drug Revenue by Application
6.1.1 Global Seasonal Allergic Rhinitis Drug Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Seasonal Allergic Rhinitis Drug Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Seasonal Allergic Rhinitis Drug Revenue Market Share by Application (2020-2031)
6.2 Global Seasonal Allergic Rhinitis Drug Sales by Application
6.2.1 Global Seasonal Allergic Rhinitis Drug Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Seasonal Allergic Rhinitis Drug Sales by Application (2020-2031) & (W Units)
6.2.3 Global Seasonal Allergic Rhinitis Drug Sales Market Share by Application (2020-2031)
6.3 Global Seasonal Allergic Rhinitis Drug Price by Application
7 Company Profiles
7.1 Allergy Therapeutics Plc
7.1.1 Allergy Therapeutics Plc Comapny Information
7.1.2 Allergy Therapeutics Plc Business Overview
7.1.3 Allergy Therapeutics Plc Seasonal Allergic Rhinitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Allergy Therapeutics Plc Seasonal Allergic Rhinitis Drug Product Portfolio
7.1.5 Allergy Therapeutics Plc Recent Developments
7.2 Faes Farma, S.A.
7.2.1 Faes Farma, S.A. Comapny Information
7.2.2 Faes Farma, S.A. Business Overview
7.2.3 Faes Farma, S.A. Seasonal Allergic Rhinitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Faes Farma, S.A. Seasonal Allergic Rhinitis Drug Product Portfolio
7.2.5 Faes Farma, S.A. Recent Developments
7.3 Glenmark Pharmaceuticals Ltd.
7.3.1 Glenmark Pharmaceuticals Ltd. Comapny Information
7.3.2 Glenmark Pharmaceuticals Ltd. Business Overview
7.3.3 Glenmark Pharmaceuticals Ltd. Seasonal Allergic Rhinitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Glenmark Pharmaceuticals Ltd. Seasonal Allergic Rhinitis Drug Product Portfolio
7.3.5 Glenmark Pharmaceuticals Ltd. Recent Developments
7.4 Hisamitsu Pharmaceutical Co., Inc.
7.4.1 Hisamitsu Pharmaceutical Co., Inc. Comapny Information
7.4.2 Hisamitsu Pharmaceutical Co., Inc. Business Overview
7.4.3 Hisamitsu Pharmaceutical Co., Inc. Seasonal Allergic Rhinitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Hisamitsu Pharmaceutical Co., Inc. Seasonal Allergic Rhinitis Drug Product Portfolio
7.4.5 Hisamitsu Pharmaceutical Co., Inc. Recent Developments
7.5 Shionogi & Co., Ltd.
7.5.1 Shionogi & Co., Ltd. Comapny Information
7.5.2 Shionogi & Co., Ltd. Business Overview
7.5.3 Shionogi & Co., Ltd. Seasonal Allergic Rhinitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Shionogi & Co., Ltd. Seasonal Allergic Rhinitis Drug Product Portfolio
7.5.5 Shionogi & Co., Ltd. Recent Developments
7.6 VentiRx Pharmaceuticals, Inc.
7.6.1 VentiRx Pharmaceuticals, Inc. Comapny Information
7.6.2 VentiRx Pharmaceuticals, Inc. Business Overview
7.6.3 VentiRx Pharmaceuticals, Inc. Seasonal Allergic Rhinitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 VentiRx Pharmaceuticals, Inc. Seasonal Allergic Rhinitis Drug Product Portfolio
7.6.5 VentiRx Pharmaceuticals, Inc. Recent Developments
7.7 Pfizer Inc.
7.7.1 Pfizer Inc. Comapny Information
7.7.2 Pfizer Inc. Business Overview
7.7.3 Pfizer Inc. Seasonal Allergic Rhinitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Pfizer Inc. Seasonal Allergic Rhinitis Drug Product Portfolio
7.7.5 Pfizer Inc. Recent Developments
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Comapny Information
7.8.2 Merck & Co., Inc. Business Overview
7.8.3 Merck & Co., Inc. Seasonal Allergic Rhinitis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Merck & Co., Inc. Seasonal Allergic Rhinitis Drug Product Portfolio
7.8.5 Merck & Co., Inc. Recent Developments
8 North America
8.1 North America Seasonal Allergic Rhinitis Drug Market Size by Type
8.1.1 North America Seasonal Allergic Rhinitis Drug Revenue by Type (2020-2031)
8.1.2 North America Seasonal Allergic Rhinitis Drug Sales by Type (2020-2031)
8.1.3 North America Seasonal Allergic Rhinitis Drug Price by Type (2020-2031)
8.2 North America Seasonal Allergic Rhinitis Drug Market Size by Application
8.2.1 North America Seasonal Allergic Rhinitis Drug Revenue by Application (2020-2031)
8.2.2 North America Seasonal Allergic Rhinitis Drug Sales by Application (2020-2031)
8.2.3 North America Seasonal Allergic Rhinitis Drug Price by Application (2020-2031)
8.3 North America Seasonal Allergic Rhinitis Drug Market Size by Country
8.3.1 North America Seasonal Allergic Rhinitis Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Seasonal Allergic Rhinitis Drug Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Seasonal Allergic Rhinitis Drug Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Seasonal Allergic Rhinitis Drug Market Size by Type
9.1.1 Europe Seasonal Allergic Rhinitis Drug Revenue by Type (2020-2031)
9.1.2 Europe Seasonal Allergic Rhinitis Drug Sales by Type (2020-2031)
9.1.3 Europe Seasonal Allergic Rhinitis Drug Price by Type (2020-2031)
9.2 Europe Seasonal Allergic Rhinitis Drug Market Size by Application
9.2.1 Europe Seasonal Allergic Rhinitis Drug Revenue by Application (2020-2031)
9.2.2 Europe Seasonal Allergic Rhinitis Drug Sales by Application (2020-2031)
9.2.3 Europe Seasonal Allergic Rhinitis Drug Price by Application (2020-2031)
9.3 Europe Seasonal Allergic Rhinitis Drug Market Size by Country
9.3.1 Europe Seasonal Allergic Rhinitis Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Seasonal Allergic Rhinitis Drug Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Seasonal Allergic Rhinitis Drug Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Seasonal Allergic Rhinitis Drug Market Size by Type
10.1.1 China Seasonal Allergic Rhinitis Drug Revenue by Type (2020-2031)
10.1.2 China Seasonal Allergic Rhinitis Drug Sales by Type (2020-2031)
10.1.3 China Seasonal Allergic Rhinitis Drug Price by Type (2020-2031)
10.2 China Seasonal Allergic Rhinitis Drug Market Size by Application
10.2.1 China Seasonal Allergic Rhinitis Drug Revenue by Application (2020-2031)
10.2.2 China Seasonal Allergic Rhinitis Drug Sales by Application (2020-2031)
10.2.3 China Seasonal Allergic Rhinitis Drug Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Seasonal Allergic Rhinitis Drug Market Size by Type
11.1.1 Asia Seasonal Allergic Rhinitis Drug Revenue by Type (2020-2031)
11.1.2 Asia Seasonal Allergic Rhinitis Drug Sales by Type (2020-2031)
11.1.3 Asia Seasonal Allergic Rhinitis Drug Price by Type (2020-2031)
11.2 Asia Seasonal Allergic Rhinitis Drug Market Size by Application
11.2.1 Asia Seasonal Allergic Rhinitis Drug Revenue by Application (2020-2031)
11.2.2 Asia Seasonal Allergic Rhinitis Drug Sales by Application (2020-2031)
11.2.3 Asia Seasonal Allergic Rhinitis Drug Price by Application (2020-2031)
11.3 Asia Seasonal Allergic Rhinitis Drug Market Size by Country
11.3.1 Asia Seasonal Allergic Rhinitis Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Seasonal Allergic Rhinitis Drug Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Seasonal Allergic Rhinitis Drug Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Seasonal Allergic Rhinitis Drug Market Size by Type
12.1.1 SAMEA Seasonal Allergic Rhinitis Drug Revenue by Type (2020-2031)
12.1.2 SAMEA Seasonal Allergic Rhinitis Drug Sales by Type (2020-2031)
12.1.3 SAMEA Seasonal Allergic Rhinitis Drug Price by Type (2020-2031)
12.2 SAMEA Seasonal Allergic Rhinitis Drug Market Size by Application
12.2.1 SAMEA Seasonal Allergic Rhinitis Drug Revenue by Application (2020-2031)
12.2.2 SAMEA Seasonal Allergic Rhinitis Drug Sales by Application (2020-2031)
12.2.3 SAMEA Seasonal Allergic Rhinitis Drug Price by Application (2020-2031)
12.3 SAMEA Seasonal Allergic Rhinitis Drug Market Size by Country
12.3.1 SAMEA Seasonal Allergic Rhinitis Drug Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Seasonal Allergic Rhinitis Drug Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Seasonal Allergic Rhinitis Drug Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Seasonal Allergic Rhinitis Drug Value Chain Analysis
13.1.1 Seasonal Allergic Rhinitis Drug Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Seasonal Allergic Rhinitis Drug Production Mode & Process
13.2 Seasonal Allergic Rhinitis Drug Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Seasonal Allergic Rhinitis Drug Distributors
13.2.3 Seasonal Allergic Rhinitis Drug Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings